Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Saw Palmetto and Improved Maximum Urinary Flow Rate

Doses used in studies

mg/day: 320 (median 320, IQR 320–320) — 1 study

Time to effect

Median: 182.5 months · IQR 182.5 months–182.5 months · Range 182.5 months–182.5 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
the patients had no adverse events related to the study drug, including prostate cancer
from: 15 years' survey of safety and efficacy of Serenoa repens extract in benign prostatic hype

1 of 1 paper

15 years' survey of safety and efficacy of Serenoa repens extract in benign prostatic hyperplasia patients with risk of progression.
- 2018-05-09
- Observational · n = 30
- Urologia 86(1)
- - Andrey Zinovievich Vinarov
  - Leonid Grigorievich Spivak
  - Darina Vladimirovna Platonova
  - Leonid Mikhailovich Rapoport
  - Dmitry Olegovich Korolev
- PubMed: 29741118
- DOI: 10.1177/0391560318772466
6 Insights on
- Improved Maximum Urinary Flow Rate
- Moderate evidence
- Clinical
The study showed an absence of progression based on both subjective (the sum of scores on the IPSS and QoL scales) and objective (prostate volume, urination rate, residual urine volume) criteria.
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
320 mg once a day